Carregant...
Risk of using hydroxychloroquine as a treatment of COVID-19
The emerging COVID-19 pandemic poses a threat to the global health care system. Given the lack of antiviral therapies or vaccines for the disease, the antimalarial drug hydroxychloroquine (HCQ) obtained much attention as a treatment for COVID-19. However, there are limited and uncertain clinical dat...
Guardat en:
| Publicat a: | Int J Risk Saf Med |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
IOS Press
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7504983/ https://ncbi.nlm.nih.gov/pubmed/32474476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JRS-200024 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|